Skip to main content
Clinical Trials/NCT06543524
NCT06543524
Completed
Not Applicable

Survival and nEonatal outComes of veRy Low Birth wEight Infants in Türkiye: Turkish Neonatal Society SECRETS-TR Study

Başakşehir Çam & Sakura City Hospital1 site in 1 country3,150 target enrollmentApril 28, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Morbidity;Infant
Sponsor
Başakşehir Çam & Sakura City Hospital
Enrollment
3150
Locations
1
Primary Endpoint
mortality rate
Status
Completed
Last Updated
last year

Overview

Brief Summary

The aim of this multi-center study was to evaluate the mortality rate and early neonatal outcomes of very low birth weight (VLBW) infants hospitalized in neonatal intensive care units (NICUs) in Türkiye. It was promoted by the Turkish Neonatology Society (TNS) and research was approved by the Cam and Sakura City Hospital Ethical Committee.

It was conducted between 28 April 2021 and 02 January 2023 and written informed consents from the families of included patients were obtained.

A total of 74 level III and IV NICUs participated to the study. All the centers had an oppurtunity to follow-up these high risk premature infants in terms of their medical staff, equipment and other neonatology sources.

The inclusion criteria consisted of preterm infants with birth weight (BW)≤1500 grams and with gestational age (GA) of 24 0/7 weeks to 31 6/7 weeks, all inborn and outborn infants admitted to NICU within the first 24 hours of life and approval of parental consent.The survival status, maternal, perinatal and neonatal characteristics, risk factors and early neonatal outcomes of all infants were recorded.

Detailed Description

The study includes the selected cohort of approximately 3000 very low birth weight preterm infants born in one year period in Turkey in level III/IV neonatal intensive care units (NICUs). Detailed information on antenatal (growth, infection), natal (neonatal resuscitation, non-invasive/invasive ventilation and surfactant administration in the delivery room) and postnatal clinical course in NICUs (ventilatory support, circulation, intestinal and cranial event status,growth, exitus) were recorded. The mortality and overall spesific morbidities of the study population will be evaluated. Also, subgroup analysis for extremely low birth weight infants, micropremies, gray zone infants (22 to 24 weeks of gestational age) will also be performed for local data of Turkey and will be used for development of local guidelines and improvements in the care of preterm infants.

Registry
clinicaltrials.gov
Start Date
April 28, 2021
End Date
September 28, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Başakşehir Çam & Sakura City Hospital
Responsible Party
Principal Investigator
Principal Investigator

Merih CETINKAYA

Professor, MD, PhD

Başakşehir Çam & Sakura City Hospital

Eligibility Criteria

Inclusion Criteria

  • Preterm infants with BW≤1500 grams and with gestational age (GA) of 24 0/7 weeks to 31 6/7 weeks,
  • All inborn and outborn infants admitted to NICU within the first 24 hours of life
  • Presence of parental consent

Exclusion Criteria

  • The larger infants than inclusion criteria,
  • Infants who died in the delivery room,
  • Infants admitted to NICU after first 24 hours of life,
  • Infants with major congenital/chromosomal abnormalities
  • Refusal of parental consent

Outcomes

Primary Outcomes

mortality rate

Time Frame: during hospitalization period, with an average of 6 months.

mortality rate of infants participated to the study

rate of prematurity-related morbidities

Time Frame: during hospitalization period or at the time of discharge whichever came first, assessed through study completion, an average of 6 months

rates of prematurity-related morbidities in infants participated to the study

Secondary Outcomes

  • Duration of hospitalization(at the time of discharge of the Neonatal Intensive Care Unit (NICU), an average of 1 year.)

Study Sites (1)

Loading locations...

Similar Trials